메뉴 건너뛰기




Volumn 21, Issue 9, 2012, Pages 1351-1369

Targeting TRPV1 for pain relief: Limits, losers and laurels

Author keywords

Capsaicin; Resiniferatoxin; Small molecule TRPV1 antagonists; TRPV1

Indexed keywords

(5 TERT BUTYL 2,3 DIHYDRO 1H INDEN 1 YL) 3 (1H INDAZOL 4 YL)UREA; 1 (2 BROMOPHENYL) 3 [1 (5 TRIFLUOROMETHYL 2 PYRIDINYL) 3 PYRROLIDINYL]UREA; 3 [2 (1 PIPERIDINYL) 6 (TRIFLUOROMETHYL) 3 PYRIDINYL] N (5,6,7,8 TETRAHYDRO 7 HYDROXY 1 NAPHTHYL)ACRYLAMIDE; ANALGESIC AGENT; AZD 1386; CAPSAICIN; DWP 05195; GRC 6211; JNJ 39439335; JTS 653; MK 2295; MR 1817; MRK 2295; N [4 [6 [4 (TRIFLUOROMETHYL)PHENYL] 4 PYRIMIDINYLOXY]BENZOTHIAZOL 2 YL]ACETAMIDE; NGD 8243; PARACETAMOL; PHE 377; PHE 575; RESINIFERATOXIN; UNCLASSIFIED DRUG; VANILLOID RECEPTOR 1; VANILLOID RECEPTOR 1 ANTAGONIST; XEN D0501;

EID: 84865336959     PISSN: 13543784     EISSN: 17447658     Source Type: Journal    
DOI: 10.1517/13543784.2012.704021     Document Type: Review
Times cited : (126)

References (102)
  • 2
    • 34248138496 scopus 로고    scopus 로고
    • The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept
    • DOI 10.1038/nrd2280, PII NRD2280
    • Szallasi A, Cortright DN, Blum CA, Eid SR. The vanilloid receptor TRPV1: 10 years from channel cloning to antagonist proof-of-concept. Nat Rev Drug Discov 2007;6:357-72 (Pubitemid 46705200)
    • (2007) Nature Reviews Drug Discovery , vol.6 , Issue.5 , pp. 357-372
    • Szallasi, A.1    Cortright, D.N.2    Blum, C.A.3    Eid, S.R.4
  • 3
    • 58149200910 scopus 로고    scopus 로고
    • Transient receptor potential channels: Targeting pain at the source
    • Patapoutian A, Tate S, Woolf CJ. Transient receptor potential channels: targeting pain at the source. Nat Rev Drug Discov 2009;8:55-68
    • (2009) Nat Rev Drug Discov , vol.8 , pp. 55-68
    • Patapoutian, A.1    Tate, S.2    Woolf, C.J.3
  • 4
    • 77956272001 scopus 로고    scopus 로고
    • International union of basic and clinical pharmacology LXXVI. current progress in the mammalian TRP ion channel family
    • Wu L-J, Sweet T-B, Clapham DE. International union of basic and clinical pharmacology. LXXVI. current progress in the mammalian TRP ion channel family. Pharmacol Rev 2010;62:381-404
    • (2010) Pharmacol Rev , vol.62 , pp. 381-404
    • Wu, L.-J.1    Sweet, T.-B.2    Clapham, D.E.3
  • 5
    • 0026083277 scopus 로고
    • Molecular target size of the vanilloid (capsaicin) receptor in pig dorsal root ganglia
    • Szallasi A, Blumberg PM. Molecular target size of the vanilloid (capsaicin) receptor in pig dorsal root ganglia. Life Sci 1991;48(19):1867-9
    • (1991) Life Sci , vol.48 , Issue.19 , pp. 1867-1869
    • Szallasi, A.1    Blumberg, P.M.2
  • 7
    • 24144490391 scopus 로고    scopus 로고
    • Extensive co-localization and heteromultimer formation of the vanilloid receptor-like protein TRPV2 and the capsaicin receptor TRPV1 in the adult rat cerebral cortex
    • DOI 10.1111/j.1460-9568.2005.04270.x
    • Liapi A, Wood JN. Extensive colocalization and heteromultimer formation of the vanilloid receptor-like protein TRPV2 and the capsaicin receptor TRPV1 in the adult rat cerebral cortex. Eur J Neurosci 2005;22:825-34 (Pubitemid 41243324)
    • (2005) European Journal of Neuroscience , vol.22 , Issue.4 , pp. 825-834
    • Liapi, A.1    Wood, J.N.2
  • 8
    • 0032970173 scopus 로고    scopus 로고
    • Vanilloid (Capsaicin) receptors and mechanisms
    • Szallasi A, Blumberg PM. Vanilloid (Capsaicin) receptors and mechanisms. Pharmacol Rev 1999;51:159-212
    • (1999) Pharmacol Rev , vol.51 , pp. 159-212
    • Szallasi, A.1    Blumberg, P.M.2
  • 10
  • 12
    • 79960580198 scopus 로고    scopus 로고
    • Modular thermal sensors in temperature-gated transient receptor potential (TRP) channels
    • Yao J, Liu B, Qin F. Modular thermal sensors in temperature-gated transient receptor potential (TRP) channels. Proc Natl Acad Sci USA 2011;108:11109-14
    • (2011) Proc Natl Acad Sci USA , vol.108 , pp. 11109-11114
    • Yao, J.1    Liu, B.2    Qin, F.3
  • 13
    • 33846807748 scopus 로고    scopus 로고
    • Transient receptor potential cation channels in disease
    • DOI 10.1152/physrev.00021.2006
    • Nilius B, Owsianik G, Voets T, Peters JA. Transient receptor potential cation channels in disease. Physiol Rev 2007;87:165-217 (Pubitemid 46207713)
    • (2007) Physiological Reviews , vol.87 , Issue.1 , pp. 165-217
    • Nilius, B.1    Owsianik, G.2    Voets, T.3    Peters, J.A.4
  • 14
    • 84872663547 scopus 로고    scopus 로고
    • A gain-of-function mutation in TRPA1 causes episodic familial pain syndrome
    • Kremeyer B, Lopera F, Cox JJ, et al. A gain-of-function mutation in TRPA1 causes episodic familial pain syndrome. Neuron 2010;66:871-80
    • (2010) Neuron , vol.66 , pp. 871-880
    • Kremeyer, B.1    Lopera, F.2    Cox, J.J.3
  • 15
    • 83755163025 scopus 로고    scopus 로고
    • SNP variant within the vanilloid TRPV1 and TRPV3 receptor genes are associated with migraine in the Spanish population
    • Carreno O, Corominas R, Fernandez-Morales J, et al. SNP variant within the vanilloid TRPV1 and TRPV3 receptor genes are associated with migraine in the Spanish population. Am J Med Genet B Neurophychiatr Genet 2012;159B:94-103
    • (2012) Am J Med Genet B Neurophychiatr Genet , vol.159 B , pp. 94-103
    • Carreno, O.1    Corominas, R.2    Fernandez-Morales, J.3
  • 16
    • 33846913452 scopus 로고    scopus 로고
    • Capsaicin receptor: TRPV1 a promiscuous TRP channel
    • Pingle SC, Matta JA, Ahern GP. Capsaicin receptor: TRPV1 a promiscuous TRP channel. Handb Exp Pharmacol 2007(179):155-71
    • (2007) Handb Exp Pharmacol , vol.179 , pp. 155-171
    • Pingle, S.C.1    Matta, J.A.2    Ahern, G.P.3
  • 17
    • 0034926291 scopus 로고    scopus 로고
    • The vanilloid receptor: A molecular gateway to the pain pathway
    • DOI 10.1146/annurev.neuro.24.1.487
    • Caterina MJ, Julius D. The vanilloid receptor: a molecular gateway to the pain pathway. Annu Rev Neurosci 2001;24:487-517 (Pubitemid 32695237)
    • (2001) Annual Review of Neuroscience , vol.24 , pp. 487-517
    • Caterina, M.J.1    Julius, D.2
  • 20
    • 34249990908 scopus 로고    scopus 로고
    • RNA interference-mediated knock-down of transient receptor potential vanilloid 1 prevents forepaw inflammatory hyperalgesia in rat
    • DOI 10.1111/j.1460-9568.2007.05584.x
    • Kasama S, Kawakubo M, Suzuki T, et al. RNA interference-mediated knock-down of transient receptor potential vanilloid 1 prevents forepaw inflammatory hyperalgesia in rat. Eur J Neurosci 2007;25:2956-63 (Pubitemid 46888823)
    • (2007) European Journal of Neuroscience , vol.25 , Issue.10 , pp. 2956-2963
    • Kasama, S.1    Kawakubo, M.2    Suzuki, T.3    Nishizawa, T.4    Ishida, A.5    Nakayama, J.6
  • 22
    • 38549118896 scopus 로고    scopus 로고
    • Capsaicin (TRPV1 agonist) therapy for pain relief: Farewell or revival?
    • DOI 10.1097/AJP.0b013e318158ed9e, PII 0000250820080200000009
    • Knotkova H, Pappagallo M, Szallasi A. Capsaicin (TRPV1 Agonist) therapy for pain relief: farewell or revival? Clin J Pain 2008;24:142-54 (Pubitemid 351156516)
    • (2008) Clinical Journal of Pain , vol.24 , Issue.2 , pp. 142-154
    • Knotkova, H.1    Pappagallo, M.2    Szallasi, A.3
  • 23
    • 80052216483 scopus 로고    scopus 로고
    • The vanilloid agonist resiniferatoxin for interventional-based pain control
    • Iadarola MJ, Mannes AJ. The vanilloid agonist resiniferatoxin for interventional-based pain control. Curr Top Med Chem 2011;11:2171-9
    • (2011) Curr Top Med Chem , vol.11 , pp. 2171-2179
    • Iadarola, M.J.1    Mannes, A.J.2
  • 25
    • 39449102203 scopus 로고    scopus 로고
    • Peripheral TRPV1 receptors as targets for drug development: New molecules and mechanisms
    • DOI 10.2174/138161208783330754
    • Gunthorpe MJ, Szallasi A. Peripheral TRPV1 receptors as targets for drugdevelopment: new molecules and mechanisms. Curr Pharm Des 2008;14:32-41 (Pubitemid 351266982)
    • (2008) Current Pharmaceutical Design , vol.14 , Issue.1 , pp. 32-41
    • Gunthorpe, M.J.1    Szallasi, A.2
  • 27
    • 84862277609 scopus 로고    scopus 로고
    • TRP channels as therapeutic targets in airway disorders: A patent review
    • [in press]
    • Preti D, Szallasi A, Patacchini R. TRP channels as therapeutic targets in airway disorders: a patent review. Exp Opin Ther Pat 2012;22:663-695. [in press]
    • (2012) Exp Opin Ther Pat , vol.22 , pp. 663-695
    • Preti, D.1    Szallasi, A.2    Patacchini, R.3
  • 28
    • 84872672964 scopus 로고    scopus 로고
    • Available from: http://www.xention.com/overactive-bladder
  • 29
    • 0001926637 scopus 로고
    • Desensitization of sensory nerve endings
    • Jancso N, Jancso A. Desensitization of sensory nerve endings. Kiserletes Orvostudomany 1949;2(2 Suppl):15
    • (1949) Kiserletes Orvostudomany , vol.2 , Issue.2 SUPPL. , pp. 15
    • Jancso, N.1    Jancso, A.2
  • 30
    • 0014128266 scopus 로고
    • Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin
    • Jancso N, Jancso-Gabor A, Szolcsanyi J. Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. Br J Pharmacol Chemother 1967;31:138-51
    • (1967) Br J Pharmacol Chemother , vol.31 , pp. 138-151
    • Jancso, N.1    Jancso-Gabor, A.2    Szolcsanyi, J.3
  • 31
    • 0017720392 scopus 로고
    • Pharmacologically induced selective degeneration of chemosensitive primary sensory neurones
    • Jancso G, Kiraly E, Jancso-Gabor A. Pharmacologically induced selective degeneration of chemosensitive primary sensory neurones. Nature 1977;270:741-3 (Pubitemid 8239254)
    • (1977) Nature , vol.270 , Issue.5639 , pp. 741-743
    • Jancso, G.1    Kiraly, E.2    Jancso Gabor, A.3
  • 33
    • 0030307629 scopus 로고    scopus 로고
    • Vanilloid-sensitive neurons: A fundamental subdivision of the peripheral nervous system
    • Szallasi A. Vanilloid-sensitive neurons: a fundamental subdivision of the peripheral nervous system. J Peripher Nerv Syst 1996;1:6-18 (Pubitemid 126674016)
    • (1996) Journal of the Peripheral Nervous System , vol.1 , Issue.1 , pp. 6-18
    • Szallasi, A.1
  • 34
    • 0026089616 scopus 로고
    • Topical capsaicin in the treatment of painful diabetic neuropathy
    • Levy DM, Abraham RR, Tomlinson DR. Topical capsaicin in the treatment of painful diabetic neuropathy. N Engl J Med 1991;324:776-7
    • (1991) N Engl J Med , vol.324 , pp. 776-777
    • Levy, D.M.1    Abraham, R.R.2    Tomlinson, D.R.3
  • 35
    • 68149094343 scopus 로고    scopus 로고
    • NGX-4010, a high-concentration capsaicin dermal patch for lasting relief of peripheral neuropathic pain
    • Noto C, Pappagallo M, Szallasi A. NGX-4010, a high-concentration capsaicin dermal patch for lasting relief of peripheral neuropathic pain. Curr Opin Investig Drugs 2009;10:702-10
    • (2009) Curr Opin Investig Drugs , vol.10 , pp. 702-710
    • Noto, C.1    Pappagallo, M.2    Szallasi, A.3
  • 36
    • 77952743084 scopus 로고    scopus 로고
    • A randomized, controlled, open-label study of the long-term effects of NGX-4010, a high-concentration capsaicin patch, on epidermal nerve fiber density and sensory function in healthy volunteers
    • Kennedy WR, Vanhove GF, Lu SP, et al. A randomized, controlled, open-label study of the long-term effects of NGX-4010, a high-concentration capsaicin patch, on epidermal nerve fiber density and sensory function in healthy volunteers. J Pain 2010;11:579-87
    • (2010) J Pain , vol.11 , pp. 579-587
    • Kennedy, W.R.1    Vanhove, G.F.2    Lu, S.P.3
  • 37
    • 77953090128 scopus 로고    scopus 로고
    • Long-term safety of NGX-4010, a high-concentration capsaicin patch, in patients with peripheral neuropathic pain
    • Simpson DM, Gazda S, Brown S, et al. Long-term safety of NGX-4010, a high-concentration capsaicin patch, in patients with peripheral neuropathic pain. J Pain Symptom Manage 2010;39:1053-64
    • (2010) J Pain Symptom Manage , vol.39 , pp. 1053-1064
    • Simpson, D.M.1    Gazda, S.2    Brown, S.3
  • 39
    • 84872650749 scopus 로고    scopus 로고
    • http://www.clinicaltrial.gov/ct2/show/NCT01228838?term= NCT01228838&rank=1
    • Neurogesx company website. Clinical trial Number (NCT01228838). Available from: http://www.neurogesx.com/c204-clinical-trial.http://www.clinicaltrial. gov/ct2/show/NCT01228838?term=NCT01228838&rank=1
    • Neurogesx Company Website. Clinical Trial Number (NCT01228838)
  • 40
    • 80051574246 scopus 로고    scopus 로고
    • Efficacy, safety, and tolerability of NGX-4010, capsaicin 8% patch, in an open-label study of patients with peripheral neuropathic pain
    • Webster LR, Peppin JF, Murphy FT, et al. Efficacy, safety, and tolerability of NGX-4010, capsaicin 8% patch, in an open-label study of patients with peripheral neuropathic pain. Diabetes Res Clin Pract 2011;93:187-97
    • (2011) Diabetes Res Clin Pract , vol.93 , pp. 187-197
    • Webster, L.R.1    Peppin, J.F.2    Murphy, F.T.3
  • 41
    • 0024382437 scopus 로고
    • Resiniferatoxin, a phorbol-related diterpene, acts as an ultrapotent analog of capsaicin, the irritant constituent in red pepper
    • DOI 10.1016/0306-4522(89)90269-8
    • Szallasi A, Blumberg PM. Resiniferatoxin, a phorbol-related diterpene, acts as an ultrapotent analog of capsaicin, the irritant constituent in red pepper. Neuroscience 1989;30:515-20 (Pubitemid 19168499)
    • (1989) Neuroscience , vol.30 , Issue.2 , pp. 515-520
    • Szallasi, A.1    Blumberg, P.M.2
  • 42
    • 0025224503 scopus 로고
    • Resiniferatoxin, an ultrapotent selective modulator of capsaicin-sensitive primary sensory neurons
    • Szolcsanyi J, Szallasi A, Szallasi Z, et al. Resiniferatoxin, an ultrapotent selective modulator of capsaicin-sensitive primary sensory neurons. J Pharmacol Exp Ther 1990;255:923-8
    • (1990) J Pharmacol Exp Ther , vol.255 , pp. 923-928
    • Szolcsanyi, J.1    Szallasi, A.2    Szallasi, Z.3
  • 43
    • 80052223776 scopus 로고    scopus 로고
    • Therapeutic targeting of TRPV1 by resiniferatoxin, from preclinical studies to clinical trials
    • Kissin I, Szallasi A. Therapeutic targeting of TRPV1 by resiniferatoxin, from preclinical studies to clinical trials. Curr Top Med Chem 2011;11:2159-70
    • (2011) Curr Top Med Chem , vol.11 , pp. 2159-2170
    • Kissin, I.1    Szallasi, A.2
  • 44
    • 49849104617 scopus 로고    scopus 로고
    • Vanilloid-induced conduction analgesia, selective, long-lasting, dose-dependent, with a low level of potential neurotoxicity
    • Kissin I. Vanilloid-induced conduction analgesia, selective, long-lasting, dose-dependent, with a low level of potential neurotoxicity. Anesth Analg 2008;107:261-71
    • (2008) Anesth Analg , vol.107 , pp. 261-271
    • Kissin, I.1
  • 45
    • 70349272715 scopus 로고    scopus 로고
    • Selective targeting of TRPV1 expressing sensory nerve terminals in the spinal cord for long lasting analgesia
    • Jeffrey JA, Yu SQ, Sikard P, et al. Selective targeting of TRPV1 expressing sensory nerve terminals in the spinal cord for long lasting analgesia. PLoS ONE 2009;4:7021-5
    • (2009) PLoS ONE , vol.4 , pp. 7021-7025
    • Jeffrey, J.A.1    Yu, S.Q.2    Sikard, P.3
  • 46
    • 0035128558 scopus 로고    scopus 로고
    • Capsaicin inhibits activation of voltage-gated sodium currents in capsaicin-sensitive trigeminal ganglion neurons
    • Liu L, Oortgiesen AM, Simon SA. Capsaicin inhibits activation of voltage-gated sodium currents in capsaicin-sensitive trigeminal ganglion neurons. J Neurophysiol 2001;85:745-58 (Pubitemid 32147776)
    • (2001) Journal of Neurophysiology , vol.85 , Issue.2 , pp. 745-758
    • Liu, L.1    Oortgiesen, M.2    Li, L.3    Simon, S.A.4
  • 47
    • 14544296132 scopus 로고    scopus 로고
    • Perineural resiniferatoxin prevents hyperalgesia in a rat model of postoperative of pain
    • DOI 10.1213/01.ANE.0000143570.75908.7F
    • Kissin I, Davison N, Bradley EL Jr. Perineural resiniferatoxin prevents hyperalgesia in a model of postoperative pain. Anesth Analg 2005;10:774-80 (Pubitemid 40300076)
    • (2005) Anesthesia and Analgesia , vol.100 , Issue.3 , pp. 774-780
    • Kissin, I.1    Davison, N.2    Bradley Jr., E.L.3
  • 48
    • 0036235474 scopus 로고    scopus 로고
    • Selective and long-lasting neural blockade with resiniferatoxin prevents inflammatory pain hypersensitivity
    • Kissin I, Bright CA, Bradley EL Jr. Selective and long-lasting blockade with resiniferatoxin prevents inflammatory pain hypersensitivity. Anesth Analg 2002;94:1253-8 (Pubitemid 34441846)
    • (2002) Anesthesia and Analgesia , vol.94 , Issue.5 , pp. 1253-1258
    • Kissin, I.1    Bright, C.A.2    Bradley Jr., E.L.3
  • 49
  • 50
    • 39449112965 scopus 로고    scopus 로고
    • Perineural resiniferatoxin selectively inhibits inflammatory hyperalgesia
    • Neubert JK, Mannes AJ, Laszlo K, et al. Perineural resiniferatoxin selectively inhibits inflammatory hyperalgesia. Mol Pain 2008;4:1-10
    • (2008) Mol Pain , vol.4 , pp. 1-10
    • Neubert, J.K.1    Mannes, A.J.2    Laszlo, K.3
  • 51
    • 34247465445 scopus 로고    scopus 로고
    • Perineural resiniferatoxin prevents the development of hyperalgesia produced by loose ligation of the sciatic nerve in rats
    • DOI 10.1213/01.ane.0000260296.01813.62, PII 0000053920070500000037
    • Kissin I, Freitas CF, Bradley EL Jr. Preineural resiniferatoxin prevents the development of hyperalgesia produced by loose ligation of the sciatic nerve in rats. Anesth Analg 2007;104:1210-16 (Pubitemid 46649947)
    • (2007) Anesthesia and Analgesia , vol.104 , Issue.5 , pp. 1210-1216
    • Kissin, I.1    Freitas, C.F.2    Bradley Jr., E.L.3
  • 52
    • 27444431571 scopus 로고    scopus 로고
    • The effects of intraarticular resiniferatoxin in experimental knee-joint arthritis
    • DOI 10.1213/01.ANE.0000180998.29890.B0
    • Kissin EY, Freitas CF, Kissin I. The effects of intraarticular resiniferatoxin in experimental knee-joint arthritis. Anesth Analg 2005;101:1433-9 (Pubitemid 41531884)
    • (2005) Anesthesia and Analgesia , vol.101 , Issue.5 , pp. 1433-1439
    • Kissin, E.Y.1    Freitas, C.F.2    Kissin, I.3
  • 54
    • 24744460256 scopus 로고    scopus 로고
    • Peripheral targeting of the trigeminal ganglia via the infraorbital foramen as a therapeutic strategy
    • Neubert JK, Mannes AJ, Keller J, et al. Peripheral targeting of the trigeminal ganglia via the infraorbital foramen as a therapeutic strategy. Brain Res Brain Res Protoc 2005;15:119-25
    • (2005) Brain Res Brain Res Protoc , vol.15 , pp. 119-125
    • Neubert, J.K.1    Mannes, A.J.2    Keller, J.3
  • 56
    • 77952099949 scopus 로고    scopus 로고
    • Prolonged analgesic response of cornea to topical resiniferatoxin, a potent TRPV1 agonist
    • Bates BD, Michell K, Keller JM, et al. Prolonged analgesic response of cornea to topical resiniferatoxin, a potent TRPV1 agonist. Pain 2010;49:522-8
    • (2010) Pain , vol.49 , pp. 522-528
    • Bates, B.D.1    Michell, K.2    Keller, J.M.3
  • 57
    • 40749097682 scopus 로고    scopus 로고
    • Advances in the design and therapeutic use of capsaicin receptor TRPV1 agonists and antagonists
    • DOI 10.1517/13543776.18.2.159
    • Gharat L, Szallasi A. Advances in the design and therapeutic use of capsaicin receptor TRPV1 agonists and antagonists. Exp Opin Ther Patents 2008;18:159-209 (Pubitemid 351377054)
    • (2008) Expert Opinion on Therapeutic Patents , vol.18 , Issue.2 , pp. 159-209
    • Gharat, L.A.1    Szallasi, A.2
  • 61
    • 77954090059 scopus 로고    scopus 로고
    • Effect of the transient receptor potential vanilloid 1 (TRPV1) antagonist compounds SB-705498, BCTC and AMG9810 in rat models of thermal hyperalgesia measured with an increasing temperature water bath
    • Tekus V, Bolcskei K, Kiss-Varga A, et al. Effect of the transient receptor potential vanilloid 1 (TRPV1) antagonist compounds SB-705498, BCTC and AMG9810 in rat models of thermal hyperalgesia measured with an increasing temperature water bath. Eur J Pharmacol 2010;641:135-41
    • (2010) Eur J Pharmacol , vol.641 , pp. 135-141
    • Tekus, V.1    Bolcskei, K.2    Kiss-Varga, A.3
  • 62
    • 79954617292 scopus 로고    scopus 로고
    • Randomized clinical trial: The efficacy of the transient receptor potential vanilloid 1 antagonist AZD1386 in human oesophageal pain
    • Krarup AL, Ny L, Astrand M, et al. Randomized clinical trial: the efficacy of the transient receptor potential vanilloid 1 antagonist AZD1386 in human oesophageal pain. Aliment Pharmacol Ther 2011;33:1113-22
    • (2011) Aliment Pharmacol Ther , vol.33 , pp. 1113-1122
    • Krarup, A.L.1    Ny, L.2    Astrand, M.3
  • 63
    • 80052237527 scopus 로고    scopus 로고
    • Therapeutic targeting of TRP channels: The TR (i)P to pain relief
    • Eid SR. Therapeutic targeting of TRP channels: the TR(i)P to pain relief. Curr Top Med Chem 2011;11:2118-30
    • (2011) Curr Top Med Chem , vol.11 , pp. 2118-2130
    • Eid, S.R.1
  • 64
    • 84872647357 scopus 로고    scopus 로고
    • Eid SR. In: 2009.Available from:http://www.arrowheadpublishers.com/ conferences/pain-therapeutics-2009/agenda/Summit
    • (2009)
    • Eid, S.R.1
  • 65
    • 84872670592 scopus 로고    scopus 로고
    • Available from: http://www.pharmeste.com/include/PHE377.pdf
  • 67
    • 0014746672 scopus 로고
    • Irreversible impairment of thermoregulation induced by capsaicin and similar pungent substances in the rats and guinea pigs
    • Jancso-Gabor A, Szolcsanyi J, Jancso N. Irreversible impairment of thermoregulation induced by capsaicin and similar pungent substances in the rats and guinea pigs. J Physiol 1970;206:495-507
    • (1970) J Physiol , vol.206 , pp. 495-507
    • Jancso-Gabor, A.1    Szolcsanyi, J.2    Jancso, N.3
  • 68
    • 0021737076 scopus 로고
    • Capsaicin and central control of thermoregulation
    • DOI 10.1016/0163-7258(84)90041-X
    • Hori T. Capsaicin and central control of thermoregulation. Pharmacol Ther 1984;26:389-416 (Pubitemid 15143740)
    • (1984) Pharmacology and Therapeutics , vol.26 , Issue.3 , pp. 389-416
    • Hori, T.1
  • 69
    • 0015214557 scopus 로고
    • Mitochondrial changes in preoptic neurons after capsaicin desensitization of the hypothalamic thermodetectors in the rat
    • Szolcsanyi J, Joo F, Jancso-Gabor A. Mitochondrial changes in preoptic neurons after capsaicin desensitization of the hypothalamic thermodetectors in the rat. Nature 1971;229:116-17
    • (1971) Nature , vol.229 , pp. 116-117
    • Szolcsanyi, J.1    Joo, F.2    Jancso-Gabor, A.3
  • 71
    • 41749117999 scopus 로고    scopus 로고
    • Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans
    • Gavva NR, Treanor JJ, Garami A, et al. Pharmacological blockade of the vanilloid receptor TRPV1 elicits marked hyperthermia in humans. Pain 2008;136:202-10
    • (2008) Pain , vol.136 , pp. 202-210
    • Gavva, N.R.1    Treanor, J.J.2    Garami, A.3
  • 74
    • 70349659983 scopus 로고    scopus 로고
    • The transient receptor potential vanilloid-1 channel in thermoregulation: A thermosensor it is not
    • Romanovsky AA, Almeida MC, Garami A, et al. The transient receptor potential vanilloid-1 channel in thermoregulation: a thermosensor it is not. Pharmacol Rev 2009;61:228-61
    • (2009) Pharmacol Rev , vol.61 , pp. 228-261
    • Romanovsky, A.A.1    Almeida, M.C.2    Garami, A.3
  • 75
    • 67649240813 scopus 로고    scopus 로고
    • Body-temperature maintenance as the predominant function of the vanilloid receptor TRPV1
    • Gavva NR. Body-temperature maintenance as the predominant function of the vanilloid receptor TRPV1. Trends Pharmacol Sci 2008;19:19-23
    • (2008) Trends Pharmacol Sci , vol.19 , pp. 19-23
    • Gavva, N.R.1
  • 76
    • 0021947967 scopus 로고
    • Capsaicin impairs preoptic serotonin-sensitive structures mediating hypothermia in rats
    • Hajos M, Obal F Jr, Jancso G, Obal F. Capsaicin impairs preoptic serotonin-sensitive structures mediating hypothermia in rats. Neurosci Lett 1985;54:97-102 (Pubitemid 15126764)
    • (1985) Neuroscience Letters , vol.54 , Issue.1 , pp. 97-102
    • Hajos, M.1    Obal Jr., F.2    Jancso, G.3    Obal, F.4
  • 79
    • 84055219327 scopus 로고    scopus 로고
    • Small molecule positive allosteric modulation of TRPV1 activation by vanilloids and acidic pH
    • Kaszas K, Keller JM, Coddou C, et al. Small molecule positive allosteric modulation of TRPV1 activation by vanilloids and acidic pH. J Pharmacol Exp Ther 2012;340:152-60
    • (2012) J Pharmacol Exp Ther , vol.340 , pp. 152-160
    • Kaszas, K.1    Keller, J.M.2    Coddou, C.3
  • 81
    • 77249125805 scopus 로고    scopus 로고
    • The paradoxical role of the transient receptor potential vanilloid 1 receptor in inflammation
    • Alawi K, Keeble J. The paradoxical role of the transient receptor potential vanilloid 1 receptor in inflammation. Pharmacol Ther 2010;125:181-91
    • (2010) Pharmacol Ther , vol.125 , pp. 181-191
    • Alawi, K.1    Keeble, J.2
  • 82
    • 84856084105 scopus 로고    scopus 로고
    • Aging reverses the role of the transient receptor potential vanilloid 1 channel in systemic inflammation from antiinflammatory to pro-inflammatory
    • Wanner SP, Garami A, Pakai E, et al. Aging reverses the role of the transient receptor potential vanilloid 1 channel in systemic inflammation from antiinflammatory to pro-inflammatory. Cell Cycle 2012;11:343-9
    • (2012) Cell Cycle , vol.11 , pp. 343-349
    • Wanner, S.P.1    Garami, A.2    Pakai, E.3
  • 83
    • 79955468809 scopus 로고    scopus 로고
    • Disruption of the transient receptor potential vanilloid 1 can affect survival, bacterial clearance, and cytokine gene expression during murine sepsis
    • Guptill V, Cui X, Khaibullina A, et al. Disruption of the transient receptor potential vanilloid 1 can affect survival, bacterial clearance, and cytokine gene expression during murine sepsis. Anesthesiology 2011;114:1190-9
    • (2011) Anesthesiology , vol.114 , pp. 1190-1199
    • Guptill, V.1    Cui, X.2    Khaibullina, A.3
  • 84
    • 35948961125 scopus 로고    scopus 로고
    • The transient receptor potential vanilloid 1 (TRPV1) receptor protects against the onset of sepsis after endotoxin
    • DOI 10.1096/fj.06-7460com
    • Clark N, Keeble J, Fernandes ES, et al. The transient receptor potential vanilloid 1 (TRPV1) protects against the onset of sepsis after endotoxin. FASEB J 2007;21:3747-55 (Pubitemid 350075162)
    • (2007) FASEB Journal , vol.21 , Issue.13 , pp. 3747-3755
    • Clark, N.1    Keeble, J.2    Fernandes, E.S.3    Starr, A.4    Liang, L.5    Sugden, D.6    De Winter, P.7    Brain, S.D.8
  • 85
    • 84857498688 scopus 로고    scopus 로고
    • TRPV1 antagonists may exacerbate sepsisin aged mice: Should we be nervous?
    • Quezado ZM, Szallasi A. TRPV1 antagonists may exacerbate sepsisin aged mice: should we be nervous? Cell Cycle 2012;11:647-8
    • (2012) Cell Cycle , vol.11 , pp. 647-648
    • Quezado, Z.M.1    Szallasi, A.2
  • 86
    • 84872671517 scopus 로고    scopus 로고
    • Available from: http://www.qutenza.com
  • 87
    • 38849118953 scopus 로고    scopus 로고
    • Adlea (ALGRX-4975), an injectable capsaicin (TRPV1 receptor agonist) formulation for longlasting pain relief
    • Remadevi R, Szallasi A. Adlea (ALGRX- 4975), an injectable capsaicin (TRPV1 receptor agonist) formulation for long lasting pain relief. IDrugs 2008;11:120-32 (Pubitemid 351196171)
    • (2008) IDrugs , vol.11 , Issue.2 , pp. 120-132
    • Remadevi, R.1    Szallisi, A.2
  • 88
    • 84872648431 scopus 로고    scopus 로고
    • Available from: http://www.bizjournals.com/sanfrancisco/stories/2010/01/ 11/story4.html
  • 90
    • 35148889475 scopus 로고    scopus 로고
    • Resiniferatoxin and botulinum toxin type A for treatment of lower urinary tract symptoms
    • DOI 10.1002/nau.20479
    • Cruz F, Dinis P. Resiniferatoxin and botulinum toxin type A for the treatment of lower urinary tract syndromes. Neurourol Urodyn 2007;26:920-7 (Pubitemid 47548229)
    • (2007) Neurourology and Urodynamics , vol.26 , Issue.6 SUPPL. , pp. 920-927
    • Cruz, F.1    Dinis, P.2
  • 92
    • 44749085444 scopus 로고    scopus 로고
    • TRPV1 null mice are protected from diet-induced obesity
    • Motter AL, Ahern GP. TRPV1 null mice are protected from diet-induced obesity. FASEB J 2008;582:2257-62
    • (2008) FASEB J , vol.582 , pp. 2257-2262
    • Motter, A.L.1    Ahern, G.P.2
  • 93
    • 80052102101 scopus 로고    scopus 로고
    • Hyperactive when young, hypoactive and overweight when aged: Connecting the dots in the story about locomotor activity, body mass, and aging in trpv1 knockout mice
    • Wanner SP, Garami A, Romanovsky AA. Hyperactive when young, hypoactive and overweight when aged: connecting the dots in the story about locomotor activity, body mass, and aging in trpv1 knockout mice. Aging 2011;3:450-4
    • (2011) Aging , vol.3 , pp. 450-454
    • Wanner, S.P.1    Garami, A.2    Romanovsky, A.A.3
  • 94
    • 84872655817 scopus 로고    scopus 로고
    • Available from: http://www.podiatryarena.com/podiatry-forum/showthread. php?t.9707
  • 95
    • 4444292549 scopus 로고    scopus 로고
    • Reduced heat sensitivity and epidermal nerve fiber immunostaining following single applications of a high-concentration capsaicin patch
    • DOI 10.1016/j.pain.2004.07.017, PII S0304395904003446
    • Malmberg AB, Mizisin AP, Calcutt NA, et al. Reduced heat sensitivity and epidermal nerve fiber immunostaining following single applications of a high-concentration capsaicin patch. Pain 2004;111:360-7 (Pubitemid 39201158)
    • (2004) Pain , vol.111 , Issue.3 , pp. 360-367
    • Malmberg, A.B.1    Mizisin, A.P.2    Calcutt, N.A.3    Von Stein, T.4    Robbins, W.R.5    Bley, K.R.6
  • 97
    • 84865311080 scopus 로고    scopus 로고
    • An open-label pilot study of high-concentration capsaicin patch in painful HIV neuropathy
    • Simpson DM, Estanislaso L, Brwn SJ, Sampson J. An open-label pilot study of high-concentration capsaicin patch in painful HIV neuropathy. J Pain Symptom Manage 2008;12:1106-12
    • (2008) J Pain Symptom Manage , vol.12 , pp. 1106-1112
    • Simpson, D.M.1    Estanislaso, L.2    Brwn, S.J.3    Sampson, J.4
  • 98
    • 84872660145 scopus 로고    scopus 로고
    • NeurogesX Inc. Form 10-K. NeurogesX Inc. Form 10-K 2008 March 26 (neurogesx.com)
    • NeurogesX, Inc. Form 10-K. NeurogesX, Inc. Form 10-K 2008 March 26 (neurogesx.com)
  • 99
    • 77957671908 scopus 로고    scopus 로고
    • Effect of duration of postherpetic neuralgia on efficacy analyses in a multicenter, randomized, controlled study of NGX-4010, an 8% capsaicin patch evaluated for the treatment of postherpetic neuralgia
    • Webster LR, Tark M, Rauck R, et al. Effect of duration of postherpetic neuralgia on efficacy analyses in a multicenter, randomized, controlled study of NGX-4010, an 8% capsaicin patch evaluated for the treatment of postherpetic neuralgia. BMC Neurol 2010;10:92
    • (2010) BMC Neurol , vol.10 , pp. 92
    • Webster, L.R.1    Tark, M.2    Rauck, R.3
  • 100
    • 55549129906 scopus 로고    scopus 로고
    • NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: A randomized, double-blind study
    • Backonfa M, Wallace MS, Blonsky ER, et al. NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomized, double-blind study. Lancet Neurol 2008;12:1106-12
    • (2008) Lancet Neurol , vol.12 , pp. 1106-1112
    • Backonfa, M.1    Wallace, M.S.2    Blonsky, E.R.3
  • 101
    • 78651257952 scopus 로고    scopus 로고
    • A multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia
    • Irving GA, Backonja MM, Dunteman E, et al. A multicenter, randomized, double-blind, controlled study of NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia. Pain Med 2011;1:99-109
    • (2011) Pain Med , vol.1 , pp. 99-109
    • Irving, G.A.1    Backonja, M.M.2    Dunteman, E.3
  • 102
    • 46049111268 scopus 로고    scopus 로고
    • Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy
    • Simpson DM, Browen S, Tobias J. Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy. Neurology 2008;28:2305-13
    • (2008) Neurology , vol.28 , pp. 2305-2313
    • Simpson, D.M.1    Browen, S.2    Tobias, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.